Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
"These are meant to be a long-term drug that's titrated slowly and appropriately and monitored effectively so that you are doing the best by the patient and setting them up for success for when you eventually do maybe want to take them off of it or titrate them down." While the lucrative obesity drug market is poised to only keep growing, many digital health companies see opportunities to address chronic conditions and support patients' long-term health
Here are some of the key benefits that I have observed in my patients: 1
Can hyperthyroidism go unnoticed
Recently, a real-world study showing association between incretin-based therapy and changes in taste perception with GLP-1 or dual GLP-1/GIP-RAs usage for around 40 weeks reported that independently to weight loss, there was an increase in sweet perception intensity up to 4.7 times and salt perception up to 3.2 times in around 20% of the participants, resulting as well in earlier satiety, and reduction of hunger and craving due to a major sensibilization to both flavors with any of these medication, although they did not mention further impact in weight loss or BMI change (170)
Semaglutide: Structurally similar to Liraglutide, Semaglutide incorporates -aminoisobutyric acid (Aib) and has a longer linker at Lys20
Athletes and active individuals
